- Home
- CRDF vs IPST Comparison
CRDF vs IPST Comparison
Compare CRDF & IPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDF | IPST |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 163.4M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | CRDF | IPST |
|---|---|---|
| Price | $2.93 | $2.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.63 | N/A |
| AVG Volume (30 Days) | ★ 914.5K | 44.8K |
| Earning Date | 11-06-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 55.05 |
| Revenue | $501,000.00 | ★ $8,294,860.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.05 |
| Revenue Growth | N/A | ★ 10.26 |
| 52 Week Low | $1.90 | $2.62 |
| 52 Week High | $5.00 | $69.00 |
Technical Indicators
Market Signals| Indicator | CRDF | IPST |
|---|---|---|
| Relative Strength Index (RSI) | 76.82 | N/A |
| Support Level | $2.32 | N/A |
| Resistance Level | $2.59 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 99.34 | 0.00 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About IPST Heritage Distilling Holding Company Inc.
Heritage Distilling Holding Co Inc is a craft distiller producing, marketing, and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon, and by shipping directly to consumers online, where legal. Currently, it sells products in the Pacific Northwest with limited distribution in other states throughout the U.S.